(Q35176366)

6 August 2017

1 reference

title

A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy (English)

1 reference

6 August 2017

1 reference

2

Carl H June

1 reference

6 August 2017

Robert H Vonderheide

1

1 reference

6 August 2017

language of work or name

1 reference

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

27

1 reference

6 August 2017

341-356

1 reference

6 August 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:27:2-3:341

6 August 2017

0 references

cites work

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

12 December 2020

Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.

1 reference

12 December 2020

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

12 December 2020

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

1 reference

12 December 2020

Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells

1 reference

12 December 2020

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

1 reference

12 December 2020

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

12 December 2020

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

1 reference

12 December 2020

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

1 reference

12 December 2020

Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors

1 reference

12 December 2020

Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28

1 reference

12 December 2020

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

12 December 2020

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

1 reference

12 December 2020

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

12 December 2020

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

1 reference

12 December 2020

Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death

1 reference

12 December 2020

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals

1 reference

12 December 2020

Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

12 December 2020

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

1 reference

12 December 2020

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Telomerase activity in normal human epithelial cells

1 reference

12 December 2020

Inducible T cell antigen 4-1BB. Analysis of expression and function

1 reference

12 December 2020

Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging

1 reference

12 December 2020

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer.

1 reference

12 December 2020

Telomeres and telomerase in normal and malignant haematopoietic cells

1 reference

12 December 2020

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

12 December 2020

In vivo proliferation of adoptively transferred tumor-infiltrating lymphocytes in mice

1 reference

12 December 2020

Creation of human tumour cells with defined genetic elements

1 reference

12 December 2020

CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation

1 reference

12 December 2020

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

12 December 2020

Identification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes

1 reference

12 December 2020

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

1 reference

12 December 2020

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

12 December 2020

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome.

1 reference

12 December 2020

Dendritic cell vaccines for cancer immunotherapy

1 reference

12 December 2020

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

12 December 2020

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

12 December 2020

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

1 reference

12 December 2020

Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model

1 reference

12 December 2020

The role of CD4+ T cell responses in antitumor immunity

1 reference

12 December 2020

Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway

1 reference

12 December 2020

Costimulation of CD28- T lymphocytes by 4-1BB ligand

1 reference

12 December 2020

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

1 reference

12 December 2020

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation

1 reference

12 December 2020

4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine

1 reference

12 December 2020

Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity

1 reference

12 December 2020

Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

1 reference

12 December 2020

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

1 reference

12 December 2020

T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivo

1 reference

12 December 2020

Active immunization against cancer with dendritic cells: the near future

1 reference

12 December 2020

Inhibition of telomerase limits the growth of human cancer cells.

1 reference

12 December 2020

Role of telomerase in normal and cancer cells

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

In vivo tracking of tumor-specific T cells

1 reference

12 December 2020

Adoptive immunotherapy:insights from donor lymphocyte infusions

1 reference

12 December 2020

The makings of a tumor rejection antigen

1 reference

12 December 2020

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

1 reference

12 December 2020

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

12 December 2020

4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Adoptive chemoimmunotherapy of a moloney lymphoma

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:27:2-3:341

1 reference

Dimensions Publication ID

6 August 2017

1011207167

0 references

Fatcat ID

release_t5fe4djntjdc5ey32epjxzbxce

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t5fe4djntjdc5ey32epjxzbxce

24 November 2022

mapped directly with Wikidata item

1 reference